Stock Events

Stock Events

Quantum Genomics 

€0.07
11
+€0+0% Thursday 16:46

Statistics

Day High
0.07
Day Low
0.07
52W High
0.21
52W Low
0.07
Volume
3,416
Avg. Volume
43
Mkt Cap
5.02M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

26FebExpected
Q1 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q3 2024
Q4 2024
0
0.33
0.67
1
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-17.78MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0D1J.LSE. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap293.34B
Novartis is a global healthcare company that operates in the pharmaceuticals sector, directly competing with Quantum Genomics in the development of cardiovascular drugs.
Pfizer
PFE
Mkt Cap156.77B
Pfizer is a large pharmaceutical company with a broad product portfolio, including treatments for cardiovascular diseases, making it a competitor to Quantum Genomics.
Merck
MRK
Mkt Cap294.39B
Merck & Co., Inc. is involved in the discovery, development, manufacturing, and marketing of pharmaceuticals, including those for cardiovascular health, competing with Quantum Genomics.
Astrazeneca
AZN
Mkt Cap317.5B
AstraZeneca operates in the biopharmaceutical sector, focusing on the development of drugs for various diseases, including cardiovascular, which competes with Quantum Genomics' focus.
AMGEN
AMGN
Mkt Cap191.53B
Amgen is a biopharmaceutical company that develops and manufactures innovative human therapeutics, including cardiovascular drugs, competing with Quantum Genomics.
Bristol-Myers Squibb
BMY
Mkt Cap122.85B
Bristol Myers Squibb is a global biopharmaceutical company with a focus on discovering, developing, and delivering innovative medicines, including for cardiovascular diseases, making it a competitor to Quantum Genomics.
Johnson & Johnson
JNJ
Mkt Cap564.35B
Johnson & Johnson operates in the pharmaceutical sector with a wide range of products, including cardiovascular drugs, directly competing with Quantum Genomics.
GSK
GSK
Mkt Cap117.55B
GlaxoSmithKline is a healthcare company that researches and develops a wide range of medicines, including those for cardiovascular diseases, competing with Quantum Genomics.
Sanofi
SNY
Mkt Cap115.14B
Sanofi is a global healthcare leader that discovers, develops, and distributes therapeutic solutions, including for cardiovascular diseases, making it a competitor to Quantum Genomics.
Abbvie
ABBV
Mkt Cap368.57B
AbbVie is a biopharmaceutical company that has a range of products for various therapeutic areas, including cardiovascular diseases, competing with Quantum Genomics.

About

Quantum Genomics Société Anonyme, a biopharmaceutical company, engages in the development of drugs to treat cardiovascular diseases. The company develops its drugs based on brain inhibition mechanism of Aminopeptidase A: BAPAI, a triple-action therapeutic platform primarily to treat high blood pressure and heart failure. It is developing firibastat, a treatment for high blood pressure, and in combination with others anti-hypertensive drugs. The company also is involved in the development of drugs for the treatment of high blood pressure as monotherapy and the prevention, as well as treatment of heart failure. Quantum Genomics Société Anonyme was incorporated in 2005 and is based in Paris, France.
Show more...
CEO
Dr. Jean-Philippe Milon
Employees
10
Country
France
ISIN
FR0011648971

Listings

STU
DE
2QG.STU
MU
DE
2QG.MU
LSE
GB
0D1J.LSE
F
DE
2QG.F

0 Comments

Share your thoughts

FAQ

What is Quantum Genomics stock price today?▼
The current price of 0D1J.LSE is €0.07 EUR — it has increased by +0% in the past 24 hours. Watch Quantum Genomics stock price performance more closely on the chart.
What is Quantum Genomics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Quantum Genomics stocks are traded under the ticker 0D1J.LSE.
What is Quantum Genomics market cap?▼
Today Quantum Genomics has the market capitalization of 5.02M
What is Quantum Genomics revenue for the last year?▼
Quantum Genomics revenue for the last year amounts to 0 EUR.
What is Quantum Genomics net income for the last year?▼
0D1J.LSE net income for the last year is -17.78M EUR.
How many employees does Quantum Genomics have?▼
As of April 23, 2026, the company has 10 employees.
In which sector is Quantum Genomics located?▼
Quantum Genomics operates in the Manufacturing sector.
When did Quantum Genomics complete a stock split?▼
Quantum Genomics has not had any recent stock splits.
Where is Quantum Genomics headquartered?▼
Quantum Genomics is headquartered in Paris, France.